David L. Snitman
Nessuna posizione attualmente
Storia della carriera di David L. Snitman
Precedenti posizioni note di David L. Snitman
| Società | Posizione | Inizio | Fine |
|---|---|---|---|
| ARRAY TECHNOLOGIES, INC. | Direttore/Membro del Consiglio | 11/10/2010 | 24/10/2012 |
| Direttore operativo | 01/05/1998 | 02/03/2015 | |
| Fondatore | 01/01/1998 | 30/06/2015 | |
| Corporate Officer/Principal | 02/03/2015 | 30/06/2015 | |
| AMGEN INC. | Direttore Tecnico/Scientifico/R&S | 01/12/1981 | - |
BaroFold, Inc.
 BaroFold, Inc. Pharmaceuticals: MajorHealth Technology BaroFold, Inc. develops and commercializes protein therapeutics. Its services include protein refolding, protein analytical and aggregate characterization, formulation stability and immunogenicity studies, and microbial expression. The company was founded by Matthew Seefeldt, Matthew Brewer, John F. Carpenter, Ted Randolph, Timothy C. Rodell, and Lyndal K. Hesterberg in 2009 and is headquartered in Aurora, CO. | Direttore/Membro del Consiglio | - | - |
Formazione di David L. Snitman
| Northeastern University | Undergraduate Degree |
| The University of Colorado | Doctorate Degree |
Statistiche
Distribuzione geografica
| Stati Uniti | 6 |
Posizioni
| Director/Board Member | 2 |
| Chief Operating Officer | 1 |
| Founder | 1 |
Settori
| Health Technology | 4 |
| Consumer Services | 3 |
Posizioni ricoperte
Attive
Inattive
Società quotate in Borsa
Aziende private
Società collegate
| Società quotate in Borsa | 1 |
|---|---|
| AMGEN INC. | Health Technology |
| Aziende private | 2 |
|---|---|
Array BioPharma, Inc.
 Array BioPharma, Inc. Pharmaceuticals: MajorHealth Technology Array BioPharma, Inc. is a biopharmaceutical company. Its focus is on the discovery, development and commercialization of targeted small molecule drugs to treat patients afflicted with cancer and other high-burden diseases. The company's products are BRAFTOVI and MEKTOVI. Its portfolio includes Binimetinib, Selumetinib, Encorafenib, Filanesib, Ipatasertib, Varltinib, Danoprevir, ARRY-797, Larotrectinib, Tucatinib, ARRY-382, Motolimod, Prexasertib, GDC-0575, LOXO-292, LOXO-195, and AK-1830. The company was founded by Kevin Koch, Anthony D. Piscopio, K. C. Nicolaou, and David L. Snitman in 1998 and is headquartered in Boulder, CO. | Health Technology |
BaroFold, Inc.
BaroFold, Inc. Pharmaceuticals: MajorHealth Technology BaroFold, Inc. develops and commercializes protein therapeutics. Its services include protein refolding, protein analytical and aggregate characterization, formulation stability and immunogenicity studies, and microbial expression. The company was founded by Matthew Seefeldt, Matthew Brewer, John F. Carpenter, Ted Randolph, Timothy C. Rodell, and Lyndal K. Hesterberg in 2009 and is headquartered in Aurora, CO. | Health Technology |
- Borsa valori
- Insiders
- David L. Snitman
- Esperienza
